Mobile App Rollout in India Clinics

October 11, 2018

MiracleFeet’s mobile app CAST is making its way to clinics around the world! Its latest stop: India.

Earlier this month. MiracleFeet India staff received training on how to use this exciting tool which was developed thanks to our $1M Google Impact Challenge Grant from After receiving the award in 2016, MiracleFeet set out to solve data management and recordkeeping challenges we identified in our partner clinics. Much of the data was being kept in paper records, which took up a lot of space and were vulnerable to weather damage. Others were being housed in clinic laptops, without cloud backup in case of technological staff use CAST mobile app to photogaph feet of Juldo who is living with neglected clubfoot

The solution developed was a mobile app called CAST, which was designed by Dimagi, a company that helps organizations like MiracleFeet integrate technology to help achieve social good. CAST was designed to run on the CommCare platform on Android phones, making it accessible to our partner clinics from Liberia to Madagascar to India. Clinic staff can work offline with the app, which is helpful in areas where internet connectivity can be unreliable. Then, once a connection is available, the app syncs the patient data and backs it up. In addition, the app also has features that help prevent user error when inputting data and allow treatment progress for a patient to be tracked in a central location.

In 2017, the app was piloted in India, Madagascar, and Republic of the Congo; it was then rolled out in Liberia in March of 2018. In October 2018, three MiracleFeet India staff and eight Clinic Executives from eight different clinics in India gathered in Lucknow, Uttar Pradesh to receive training on the final version of the app. The enthusiastic participants were able to get an overview of the app’s features and then practice entering data in real time. They reported being excited to return to their clinics and begin using CAST.

What’s next for CAST? The app will roll out in Latin America in January, and then in clinics throughout the rest of the Asia region in the spring of 2019.